Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbzena Regulatory News (ABZA)

  • There is currently no data for ABZA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TR-1: Notification of major holdings

29 Aug 2017 14:59

RNS Number : 2120P
Abzena PLC
29 August 2017
 

TR-1: Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

ABZENA PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

HARGREAVE HALE LIMITED

City and country of registered office (if applicable)

BLACKPOOL, ENGLAND

4. Full name of shareholder(s) (if different from 3.)v

Name

DISCRETIONARY CLIENTS

City and country of registered office (if applicable)

As above

5. Date on which the threshold was crossed or reachedvi:

24 / 08 / 2017

6. Date on which issuer notified (DD/MM/YYYY):

29 / 08 / 2017

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

12.0337

12.0337

 

213,639,236

 

Position of previous notification (if

applicable)

11.9401

11.9401

 

 

 

 

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00BN65QN46

25,708,700

12.0337

 

SUBTOTAL 8. A

25,708,700

12.0337

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

20,925,000 of the resulting shares are held in a unit trust operated by Marlborough Fund Managers Ltd, for whom Hargreave Hale Ltd manages the portfolio of investments on a discretionary basis.

 

Place of completion

HARGREAVE HALE LTD, BLACKPOOL, ENGLAND

Date of completion

29 AUGUST 2017

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLBXGDILUDBGRC
Date   Source Headline
17th Aug 201810:17 amRNSForm 8.5 (EPT/RI) Abzena
17th Aug 20188:52 amRNSForm 8.3 - ABZENA PLC
17th Aug 20188:19 amRNSForm 8.5 (EPT/RI) - Abzena Plc
16th Aug 20187:19 amRNSUpdate on partial monetisation
16th Aug 20187:16 amRNSRecommended Cash Offer for Abzena plc
8th Aug 20187:00 amRNSFirst ABZENA Inside GMP drug substance released
6th Jul 20183:55 pmRNSBlocklisting update
2nd Jul 20187:00 amRNSAbzena and Telix sign manufacturing agreement
19th Jun 201812:28 pmRNSAnnual Report and Accounts
14th Jun 20187:00 amRNSFunding update
4th Jun 20187:00 amRNSFinal Results
29th May 20189:00 amRNSNotice of full year results
16th Apr 20187:25 amRNSPre-Close Period Trading Update FY2018
9th Apr 20188:25 amRNSTermination of licence agreement
29th Mar 20185:34 pmRNSIssue of Ordinary Shares
5th Mar 20187:00 amRNSPacificGMP Stanford Settlement
23rd Feb 20187:15 amRNSHardman & Co Research: Investing for growth
5th Jan 20187:00 amRNSBusiness update on US and UK facilities
3rd Jan 20186:12 pmRNSBlock Listing Update
12th Dec 20177:00 amRNSHalf year results: Growth strategy progressing
11th Dec 20177:00 amRNSAbzena secures ADC manufacturing services contract
21st Nov 20179:51 amRNSNotice of half year results
8th Nov 20172:28 pmRNSTR-1: Notification of major holdings
24th Oct 20174:15 pmRNSExercise of options
27th Sep 20177:15 amRNSHardman Research: AGM statement fully discounted
19th Sep 20172:25 pmRNSTR-1: Notification of Major Holdings
19th Sep 20177:00 amRNSAppointment of Non-Executive Director
18th Sep 20175:41 pmRNSTR-1: Notification of Major Holdings
14th Sep 201712:46 pmRNSResult of AGM
14th Sep 20177:00 amRNSTrading Update
31st Aug 201712:15 pmRNSHardman Resrch: Accelerating towards profitability
29th Aug 20172:59 pmRNSTR-1: Notification of major holdings
29th Aug 20177:00 amRNSNotification of claim
21st Aug 20171:44 pmRNSHolding(s) in Company
28th Jul 201712:27 pmRNSNotice of AGM
18th Jul 20177:00 amRNSAbzena and Telix sign licence agreement
11th Jul 20177:00 amRNSAbzena and OBI Pharma sign licence agreement
4th Jul 201711:24 amRNSExercise of Options
3rd Jul 20176:11 pmRNSBlock Listing Update
30th Jun 20175:19 pmRNSTR-1: Notification of Major Interest in Shares
19th Jun 20175:18 pmRNSAnnual Report and Accounts
13th Jun 20177:00 amRNSFinal Results
26th May 20175:24 pmRNSTR-1: Notification of Major Interest in Shares
24th May 20177:11 amRNSAbzena notes True North Therapeutics acquisition
16th May 20177:00 amRNSNotice of Full Year Results
3rd May 201712:58 pmEQSEdison issues outlook on Abzena (ABZA)
3rd May 20177:15 amRNSHardman: Acceleration towards profitability
27th Apr 201711:09 amRNSTR-1: Notification of Major Interest in Shares
21st Apr 201711:21 amRNSInnovations invests £2.9m in Abzena placing
21st Apr 201711:20 amRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.